Xuegang Xu Selected Research

bufogenin

3/2021	Retraction Note to: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.
12/2019	Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuegang Xu Research Topics

Disease

3	Neoplasms (Cancer) 03/2021 - 04/2014
2	Alopecia (Baldness) 01/2022 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 12/2019
1	Cicatrix (Scar) 01/2020
1	Acne Vulgaris 07/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2014
1	Skin Diseases (Skin Disease) 04/2014

Drug/Important Bio-Agent (IBA)

2	bufogeninIBA 03/2021 - 12/2019
1	Bone Morphogenetic Protein 6IBA 01/2022
1	fibroblast growth factor 18IBA 01/2022
1	SolutionsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Minoxidil (Rogaine)FDA LinkGeneric 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	huachansuIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 12/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2014
1	shikoninIBA 04/2014
1	Interleukin-17 (Interleukin 17)IBA 04/2014

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 07/2014